Anastasi A, Brown MA, Kembhavi AA, Nicklin MJ, Sayers CA, Sunter DC, et al. Cystatin, a protein inhibitor of cysteine proteinases. Improved purification from egg white, characterization, and detection in chicken serum. Biochem J. 1983;211(1):129–38.
Article
CAS
PubMed
PubMed Central
Google Scholar
Jin L, Zhang Y, Li H, Yao L, Fu D, Yao X, et al. Differential secretome analysis reveals CST6 as a suppressor of breast cancer bone metastasis. Cell Res. 2012;22(9):1356–73.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kopitar-Jerala N. Innate Immune Response in Brain, NF-Kappa B Signaling and Cystatins. Front Mol Neurosci. 2015;8:73.
Article
PubMed
PubMed Central
CAS
Google Scholar
Breznik B, Mitrovic A, Lah TT, Kos J. Cystatins in cancer progression: More than just cathepsin inhibitors. Biochimie. 2019;166:233–50.
Article
CAS
PubMed
Google Scholar
Shamsi A, Bano B. Journey of cystatins from being mere thiol protease inhibitors to at heart of many pathological conditions. Int J Biol Macromol. 2017;102:674–93.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhang WP, Wang Y, Tan D, Xing CG. Cystatin 2 leads to a worse prognosis in patients with gastric cancer. J Biol Regul Homeost Agents. 2020;34(6):2059–67.
CAS
PubMed
Google Scholar
Zhang YQ, Zhang JJ, Song HJ, Li DW. Overexpression of CST4 promotes gastric cancer aggressiveness by activating the ELFN2 signaling pathway. Am J Cancer Res. 2017;7(11):2290–304.
CAS
PubMed
PubMed Central
Google Scholar
Dai DN, Li Y, Chen B, Du Y, Li SB, Lu SX, et al. Elevated expression of CST1 promotes breast cancer progression and predicts a poor prognosis. J Mol Med (Berl). 2017;95(8):873–86.
Article
CAS
Google Scholar
Jiang J, Liu HL, Tao L, Lin XY, Yang YD, Tan SW, et al. Let7d inhibits colorectal cancer cell proliferation through the CST1/p65 pathway. Int J Oncol. 2018;53(2):781–90.
CAS
PubMed
Google Scholar
Cui Y, Sun D, Song R, Zhang S, Liu X, Wang Y, et al. Upregulation of cystatin SN promotes hepatocellular carcinoma progression and predicts a poor prognosis. J Cell Physiol. 2019;234(12):22623–34.
Article
CAS
PubMed
PubMed Central
Google Scholar
Oh BM, Lee SJ, Cho HJ, Park YS, Kim JT, Yoon SR, et al. Cystatin SN inhibits auranofin-induced cell death by autophagic induction and ROS regulation via glutathione reductase activity in colorectal cancer. Cell Death Dis. 2017;8(3):e2682.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ding J, Wang X, Gao J, Song T. Silencing of cystatin SN abrogates cancer progression and stem cell properties in papillary thyroid carcinoma. FEBS Open Bio. 2021.
Chen S, Liu Y, Zhang K, Chen L. CST1 Promoted Gastric Cancer Migration and Invasion Through Activating Wnt Pathway. Cancer Manag Res. 2021;13:1901–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–49.
Article
PubMed
Google Scholar
Biswas D, Birkbak NJ, Rosenthal R, Hiley CT, Lim EL, Papp K, et al. A clonal expression biomarker associates with lung cancer mortality. Nat Med. 2019;25(10):1540–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Stuelten CH, Parent CA, Montell DJ. Cell motility in cancer invasion and metastasis: insights from simple model organisms. Nat Rev Cancer. 2018;18(5):296–312.
Article
CAS
PubMed
PubMed Central
Google Scholar
Liu K, Yu Q, Li H, Xie C, Wu Y, Ma D, et al. BIRC7 promotes epithelial-mesenchymal transition and metastasis in papillary thyroid carcinoma through restraining autophagy. Am J Cancer Res. 2020;10(1):78–94.
PubMed
PubMed Central
Google Scholar
Chin L, Andersen JN, Futreal PA. Cancer genomics: from discovery science to personalized medicine. Nat Med. 2011;17(3):297–303.
Article
CAS
PubMed
Google Scholar
Warde-Farley D, Donaldson SL, Comes O, Zuberi K, Badrawi R, Chao P, et al. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res. 2010;38(Web Server issue):W214–20.
Article
CAS
PubMed
PubMed Central
Google Scholar
Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607–13.
Article
CAS
PubMed
Google Scholar
Tang Z, Kang B, Li C, Chen T, Zhang Z. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019;47(W1):W556–60.
Article
CAS
PubMed
PubMed Central
Google Scholar
Brlek P, Kafka A, Bukovac A, Pecina-Slaus N. Integrative cBioPortal Analysis Revealed Molecular Mechanisms That Regulate EGFR-PI3K-AKT-mTOR Pathway in Diffuse Gliomas of the Brain. Cancers (Basel). 2021;13(13):3247.
Article
CAS
Google Scholar
Gan J, Li Y, Meng Q. Systematic Analysis of Expression Profiles and Prognostic Significance for FAM83 Family in Non-small-Cell Lung Cancer. Front Mol Biosci. 2020;7:572406.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mizuno H, Kitada K, Nakai K, Sarai A. PrognoScan: a new database for meta-analysis of the prognostic value of genes. BMC Med Genet. 2009;2:18.
Google Scholar
Kanehisa M, Furumichi M, Sato Y, Ishiguro-Watanabe M, Tanabe M. KEGG: integrating viruses and cellular organisms. Nucleic Acids Res. 2021;49(D1):D545–51.
Article
CAS
PubMed
Google Scholar
The Gene Ontology C. The Gene Ontology Resource: 20 years and still GOing strong. Nucleic Acids Res. 2019;47(D1):D330–8.
Article
CAS
Google Scholar
Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation (N Y). 2021;2(3):100141.
Google Scholar
Cosset E, Ilmjarv S, Dutoit V, Elliott K, von Schalscha T, Camargo MF, et al. Glut3 addiction is a druggable vulnerability for a molecularly defined subpopulation of glioblastoma. Cancer Cell. 2017;32(6):856–68.e855.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lentini JM, Alsaif HS, Faqeih E, Alkuraya FS, Fu D. DALRD3 encodes a protein mutated in epileptic encephalopathy that targets arginine tRNAs for 3-methylcytosine modification. Nat Commun. 2020;11(1):2510.
Article
CAS
PubMed
PubMed Central
Google Scholar
Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008;3(6):1101–8.
Article
CAS
PubMed
Google Scholar
Melgar-Lesmes P, Luquero A, Parra-Robert M, Mora A, Ribera J, Edelman ER, et al. Graphene-dendrimer nanostars for targeted macrophage overexpression of metalloproteinase 9 and hepatic fibrosis precision therapy. Nano Lett. 2018;18(9):5839–45.
Article
CAS
PubMed
PubMed Central
Google Scholar
Duchamp de Lageneste O, Julien A, Abou-Khalil R, Frangi G, Carvalho C, Cagnard N, et al. Periosteum contains skeletal stem cells with high bone regenerative potential controlled by Periostin. Nat Commun. 2018;9(1):773.
Article
PubMed
PubMed Central
CAS
Google Scholar
Kosinsky RL, Zerche M, Saul D, Wang X, Wohn L, Wegwitz F, et al. USP22 exerts tumor-suppressive functions in colorectal cancer by decreasing mTOR activity. Cell Death Differ. 2020;27(4):1328–40.
Article
CAS
PubMed
Google Scholar
Tan WCC, Nerurkar SN, Cai HY, Ng HHM, Wu D, Wee YTF, et al. Overview of multiplex immunohistochemistry/immunofluorescence techniques in the era of cancer immunotherapy. Cancer Commun (Lond). 2020;40(4):135–53.
Article
Google Scholar
Zhang XW, Li L, Hu WQ, Hu MN, Tao Y, Hu H, et al. Neurokinin-1 receptor promotes non-small cell lung cancer progression through transactivation of EGFR. Cell Death Dis. 2022;13(1):41.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wu D, Yan B, Wang Y, Wang C, Zhang L. Prognostic and pharmacologic value of cystatin SN for chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2021;148(2):450–60.
Article
CAS
PubMed
Google Scholar
Choi EH, Kim JT, Kim JH, Kim SY, Song EY, Kim JW, et al. Upregulation of the cysteine protease inhibitor, cystatin SN, contributes to cell proliferation and cathepsin inhibition in gastric cancer. Clin Chim Acta. 2009;406(1–2):45–51.
Article
CAS
PubMed
Google Scholar
Liu Y, Ma H, Wang Y, Du X, Yao J. Cystatin SN affects cell proliferation by regulating the ERalpha/PI3K/AKT/ERalpha loopback pathway in breast cancer. Onco Targets Ther. 2019;12:11359–69.
Article
CAS
PubMed
PubMed Central
Google Scholar
Liu Y, Liao L, An C, Wang X, Li Z, Xu Z, et al. alpha-Enolase Lies Downstream of mTOR/HIF1alpha and Promotes Thyroid Carcinoma Progression by Regulating CST1. Front Cell Dev Biol. 2021;9:670019.
Article
PubMed
PubMed Central
Google Scholar
Wang J, Yu L, Sun Y, Zhang L, Tu M, Cai L, et al. Development and Evaluation of Serum CST1 Detection for Early Diagnosis of Esophageal Squamous Cell Carcinoma. Cancer Manag Res. 2021;13:8341–52.
Article
CAS
PubMed
PubMed Central
Google Scholar
Masuda M, Uno Y, Ohbayashi N, Ohata H, Mimata A, Kukimoto-Niino M, et al. TNIK inhibition abrogates colorectal cancer stemness. Nat Commun. 2016;7:12586.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kuenzi BM, Ideker T. A census of pathway maps in cancer systems biology. Nat Rev Cancer. 2020;20(4):233–46.
Article
CAS
PubMed
PubMed Central
Google Scholar
Jiang J, Liu HL, Liu ZH, Tan SW, Wu B. Identification of cystatin SN as a novel biomarker for pancreatic cancer. Tumour Biol. 2015;36(5):3903–10.
Article
CAS
PubMed
Google Scholar
Kim JT, Lee SJ, Kang MA, Park JE, Kim BY, Yoon DY, et al. Cystatin SN neutralizes the inhibitory effect of cystatin C on cathepsin B activity. Cell Death Dis. 2013;4:e974.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cao X, Li Y, Luo RZ, Zhang L, Zhang SL, Zeng J, et al. Expression of Cystatin SN significantly correlates with recurrence, metastasis, and survival duration in surgically resected non-small cell lung cancer patients. Sci Rep. 2015;5:8230.
Article
CAS
PubMed
PubMed Central
Google Scholar
Jakos T, Pislar A, Jewett A, Kos J. Cysteine Cathepsins in Tumor-Associated Immune Cells. Front Immunol. 2019;10:2037.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kos J, Nanut MP, Prunk M, Sabotic J, Dautovic E, Jewett A. Cystatin F as a regulator of immune cell cytotoxicity. Cancer Immunol Immunother. 2018;67(12):1931–8.
Article
CAS
PubMed
Google Scholar
Laurent-Matha V, Huesgen PF, Masson O, Derocq D, Prebois C, Gary-Bobo M, et al. Proteolysis of cystatin C by cathepsin D in the breast cancer microenvironment. FASEB J. 2012;26(12):5172–81.
Article
CAS
PubMed
Google Scholar
Biffi G, Tuveson DA. Diversity and Biology of Cancer-Associated Fibroblasts. Physiol Rev. 2021;101(1):147–76.
Article
PubMed
Google Scholar
Kalluri R. The biology and function of fibroblasts in cancer. Nat Rev Cancer. 2016;16(9):582–98.
Article
CAS
PubMed
Google Scholar
Goulet CR, Champagne A, Bernard G, Vandal D, Chabaud S, Pouliot F, et al. Cancer-associated fibroblasts induce epithelial-mesenchymal transition of bladder cancer cells through paracrine IL-6 signalling. BMC Cancer. 2019;19(1):137.
Article
PubMed
PubMed Central
Google Scholar
Teijeira A, Garasa S, Ochoa MC, Villalba M, Olivera I, Cirella A, et al. IL8, Neutrophils, and NETs in a Collusion against Cancer Immunity and Immunotherapy. Clin Cancer Res. 2021;27(9):2383–93.
Article
CAS
PubMed
Google Scholar
Strilic B, Yang L, Albarran-Juarez J, Wachsmuth L, Han K, Muller UC, et al. Tumour-cell-induced endothelial cell necroptosis via death receptor 6 promotes metastasis. Nature. 2016;536(7615):215–8.
Article
CAS
PubMed
Google Scholar
Xia J, Minamino S, Kuwabara K. CAR-expressing NK cells for cancer therapy: a new hope. Biosci Trends. 2020;14(5):354–9.
Article
CAS
PubMed
Google Scholar